The CLEAR Study
Who can take part?
You may be eligible to participate if you are:
- Aged between 18 to 75 years
- Using hybrid closed-loop (HCL) therapy or multiple daily injections (MDI)
- Have been diagnosed with type 1 diabetes for 10 years or more
- Have an HbA1c less than 10.5%
- Can understand and write in English (study materials are only available in the English language)
What does participation involve?
Participation in the study runs for 2 years (approximately 27-30 months) and includes:
- Attendance of at least 20 study visits which are a mix of in-person and remote visits
- Phone and online appointments
- Undertake three specialised “clamp tests” at the clinical site
- Take part in education sessions facilitated by diabetes nurse educators
Reimbursement
There is no additional cost to you as the participant in this study. You will be reimbursed a maximum of $1871.25 if you complete all study activities.
Study Location
St Vincent’s Public Hospital, Melbourne
Contact
Diabetes Technology Research Group Melbourne via email dtrg-t1research@unimelb.edu.au or call on 03 9231 2757.
This study has received ethical approval from the St Vincent’s Hospital Melbourne (Public) Human Research Ethics Committee ref #183/24